Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines

Background: In 1989, Botulinum toxin (BoNT) was accepted by the FDA for the management of some ophthalmic disorders. Although it was initially considered a lethal toxin, in recent times, Botulinum toxin A (BoNT-A), which is the more used serotype, has expanded to cover different clinical conditions,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dima, Lorena, Bălan, Andreea, Moga, Marius Alexandru, Dinu, Cătălina Georgeta, Dimienescu, Oana Gabriela, Varga, Ioana, Neculau, Andrea Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722780/
https://www.ncbi.nlm.nih.gov/pubmed/31398813
http://dx.doi.org/10.3390/toxins11080465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722780/
https://www.ncbi.nlm.nih.gov/pubmed/31398813
http://dx.doi.org/10.3390/toxins11080465

Ejemplares similares